Becton Dickinson & Company
Research Becton Dickinson & Company (BDX) on Bullrun: valuation model: 38.2% overvalued, market cap USD 42.76B, P/E 39.4, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBDX
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal38.2% overvalued
- Market capUSD 42.76B
- P/E39.4
- Dividend yield2.4%
- Financial periodFY2025
- RevenueUSD 21.84B
- Revenue growth8.2%
- Net incomeUSD 1.68B
- Free cash flowUSD 2.67B
- Gross margin45.4%
Valuation Snapshot
Bullrun's latest valuation model marks Becton Dickinson & Company as 38.2% overvalued; latest market cap is USD 42.76B; P/E is 39.4; dividend yield is 2.4%.
About Becton Dickinson & Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Frequently asked questions
Is Becton Dickinson & Company overvalued or undervalued?
Bullrun's valuation model currently marks Becton Dickinson & Company as 38.2% overvalued.
What is Becton Dickinson & Company's market cap?
Becton Dickinson & Company's market capitalization is USD 42.76B.
What is Becton Dickinson & Company's P/E ratio?
Becton Dickinson & Company's price-to-earnings (P/E) ratio is 39.4.
Does Becton Dickinson & Company pay a dividend?
Becton Dickinson & Company has a dividend yield of 2.4%.
What does Becton Dickinson & Company do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.